Scotland · NHS Scotland MSAN
Estradiol (Estradot®) 50micrograms/24 hours, 75micrograms/24 hours, and
MSAN(2024)69 · Level 2 · issued 27 Dec 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| will be out of stock until mid-January 2025. | Out of stock | mid-January 2025 |
| 2. Estradiol (Estradot®) 50micrograms/24hours transdermal patches will be out of stock until late | Out of stock | late |
| are available and can support a full uplift in demand. | Available | — |
| 4. FemSeven® (estradiol) transdermal patches (once weekly application) remain available and can | Available | — |
| 5. Progynova® (estradiol) transdermal patches also remain available but cannot support an uplift in | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.